Your session is about to expire
← Back to Search
Cognitive Rehabilitation and Exercise for Multiple Sclerosis (COMBINE Trial)
N/A
Recruiting
Led By Carly Wender, PhD
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be relapse and steroid-free for at least 30 days
Moderate self-reported mobility disability, based on the Patient Determined Disease Steps scale (PDDS)
Must not have
History of neurological disorders besides MS or history of uncontrolled psychiatric disorders (ex: major depression)
Currently use medications that may impact cognition (ex: steroids, benzodiazepines)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 1 and 2 (pre-intervention) and weeks 15 and 16 (post-intervention)
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to see if a combination of cognitive rehabilitation and exercise can improve new learning and memory in people with multiple sclerosis and mobility issues.
Who is the study for?
This trial is for adults aged 18-70 with Multiple Sclerosis, who primarily speak English and have moderate mobility issues but are currently inactive. They must not have had a relapse or taken steroids in the last month and should be right-handed. People with other neurological disorders, uncontrolled psychiatric conditions, contraindications to exercise, certain medications affecting cognition, pregnancy, or MRI contraindications cannot participate.
What is being tested?
The study tests if combining cognitive rehabilitation (using Kessler Foundation's modified Story Memory Technique) with physical exercises (stretching/toning and aerobic training enhanced by virtual reality) can improve new learning and memory in people with Multiple Sclerosis who also have mobility disabilities.
What are the potential side effects?
While specific side effects are not detailed here, participants may experience general discomforts associated with physical exercises such as muscle soreness or fatigue. Cognitive rehabilitation typically does not cause side effects but may include mental fatigue.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I haven't had a relapse or taken steroids in the last 30 days.
Select...
I have some difficulty walking or moving around.
Select...
I am between 18 and 70 years old.
Select...
I have been diagnosed with MS by a neurologist.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have no neurological disorders other than MS and my mental health is stable.
Select...
I am taking medication that could affect my thinking or memory.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ weeks 1 and 2 (pre-intervention) and weeks 15 and 16 (post-intervention)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 1 and 2 (pre-intervention) and weeks 15 and 16 (post-intervention)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in everyday memory
Change in objective new learning and memory (NLM).
Secondary study objectives
Change in hippocampal function
Change in hippocampal volume
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Cognitive Rehabilitation + Stretching and ToningExperimental Treatment2 Interventions
In the cognitive rehabilitation and stretching and toning (S/T) exercise condition, participants will complete 12 weeks of supervised S/T activities 3 days per week over the 12 week period. For seven weeks, participants will only complete S/T. During weeks 8-12, participants will complete the Kessler Foundation modified story Memory Technique (KF-mSMT®), a memory retraining program on 2 of the 3 days per week.
Group II: Cognitive Rehabilitation + Aerobic Exercise with Virtual Reality (VR)Experimental Treatment2 Interventions
In the cognitive rehabilitation and aerobic exercise with VR condition, participants will complete a supervised, aerobic exercise training program (AET) integrated with virtual reality (Ideally Designed Exercise to Accelerate Learning/memory; IDEAL) three days per week over a 12 week period. For seven weeks, participants will only complete IDEAL. For weeks 8-12, participants will complete the Kessler Foundation modified story Memory Technique (KF-mSMT®), a memory retraining program on 2 of the 3 days per week.
Find a Location
Who is running the clinical trial?
National Multiple Sclerosis SocietyOTHER
98 Previous Clinical Trials
10,486 Total Patients Enrolled
96 Trials studying Multiple Sclerosis
10,132 Patients Enrolled for Multiple Sclerosis
Kessler FoundationLead Sponsor
184 Previous Clinical Trials
11,191 Total Patients Enrolled
33 Trials studying Multiple Sclerosis
1,579 Patients Enrolled for Multiple Sclerosis
Carly Wender, PhDPrincipal InvestigatorKessler Foundation
1 Previous Clinical Trials
24 Total Patients Enrolled
1 Trials studying Multiple Sclerosis
24 Patients Enrolled for Multiple Sclerosis